How I knew I had inflammatory breast cancer?

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer that often presents with distinctive clinical features, making its recognition crucial for timely diagnosis and treatment. The hallmark symptoms of IBC include rapid onset of breast swelling, erythema, and skin changes resembling “peau d’orange” (orange peel skin) (Siddiqui et al., 2022; Judd, 2023). These symptoms can sometimes be mistaken for benign conditions such as mastitis, leading to diagnostic delays (Siddiqui et al., 2022; Isichei, 2014). In fact, the misdiagnosis of IBC as mastitis or other inflammatory conditions is a common challenge due to overlapping clinical presentations (Siddiqui et al., 2022; Isichei, 2014; Kruger, 2012).

The diagnosis of IBC is primarily based on clinical examination and imaging studies, which reveal characteristic skin changes and breast edema. Pathological confirmation through biopsy is often necessary to differentiate IBC from other conditions (Yeh et al., 2013; Isichei, 2014). The presence of dermal lymphatic involvement, where cancer cells infiltrate the lymphatic vessels in the skin, is a defining feature of IBC (Hyakudomi et al., 2013; An et al., 2016). Imaging techniques, including mammography and ultrasound, play a critical role in identifying these changes, although they may not always detect the underlying malignancy, especially in early stages (Judd, 2023; Yeh et al., 2013; Siddiqui et al., 2022).

Patients may also experience systemic symptoms such as pain, itching, and changes in the nipple, which can further complicate the diagnosis (Sosnowska-Sienkiewicz & Mańkowski, 2021; Siddiqui et al., 2022). The rapid progression of symptoms, particularly the swelling and redness of the breast, is a significant indicator that may prompt healthcare providers to consider IBC as a differential diagnosis (Kruger, 2012; Siddiqui et al., 2022). In some cases, patients have reported being misdiagnosed multiple times before receiving a correct diagnosis of IBC, highlighting the need for heightened awareness among clinicians regarding this aggressive form of breast cancer (Richardson & Cottier, 2017; Isichei, 2014).

Furthermore, the prognosis for IBC is notably poor, with survival rates significantly lower than those for other types of breast cancer, underscoring the importance of early detection and intervention (Yeh et al., 2013; Schlichting et al., 2012). The aggressive nature of IBC necessitates a multidisciplinary approach to treatment, often involving chemotherapy, surgery, and radiation therapy (Yeh et al., 2013; Li et al., 2010). Given the complexity of its presentation and the potential for misdiagnosis, it is essential for both patients and healthcare providers to remain vigilant for the signs and symptoms of inflammatory breast cancer.

In summary, recognizing the clinical features of inflammatory breast cancer, understanding the diagnostic challenges, and acknowledging the urgency of timely intervention are critical for improving outcomes in affected patients.

References #

1. An, J., Woo, J., & Lee, S. (2016). Non-puerperal mastitis masking pre-existing breast malignancy: importance of follow-up imaging. Ultrasonography, 35(2), 159-163. https://doi.org/10.14366/usg.15024
2. Hyakudomi, M., Inao, T., Minari, Y., Itakura, M., Maruyama, R., & Tajima, Y. (2013). A case of male inflammatory breast cancer. International Cancer Conference Journal, 2(3), 183-187. https://doi.org/10.1007/s13691-013-0087-9
3. Isichei, W. (2014). Inflammatory breast cancer: still a diagnostic dilemma. Journal of Surgery, 2(3), 42. https://doi.org/10.11648/j.js.20140203.12
4. Judd, D. (2023). Inflammatory skin change from a small 0.9 cm primary breast cancer not seen on initial imaging: a case report. Cureus. https://doi.org/10.7759/cureus.39491
5. Kruger, S. (2012). Breast cancer presenting as subclavian/axillary deep vein thrombosis and upper limb lymphoedema. Annals of the Royal College of Surgeons of England, 94(2), e55-e56. https://doi.org/10.1308/003588412×13171221500745
6. Li, B., Sicard, M., Ampil, F., Abreo, F., Lilien, D., Chu, Q., … & Burton, G. (2010). Trimodal therapy for inflammatory breast cancer: a surgeon’s perspective. Oncology, 79(1-2), 3-12. https://doi.org/10.1159/000318529
7. Richardson, T. and Cottier, F. (2017). An unexpected diagnosis of breast malignancy. Annals of the Royal College of Surgeons of England, 99(6), e180-e182. https://doi.org/10.1308/rcsann.2017.0100
8. Schlichting, J., Soliman, A., Schairer, C., Schottenfeld, D., & Merajver, S. (2012). Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the surveillance, epidemiology, and end results database, 1990–2008. 
9. Breast Cancer Research and Treatment, 134(3), 1257-1268. https://doi.org/10.1007/s10549-012-2133-2
10. Siddiqui, M., Alsarhan, M., Almutairi, F., Ahmed, S., Alroudan, D., Alotaibi, S., … & Siddiqui, M. (2022). An overview of inflammatory breast cancer. International Journal of Community Medicine and Public Health, 10(1), 480. https://doi.org/10.18203/2394-6040.ijcmph20223316
11. Sosnowska-Sienkiewicz, P. and Mańkowski, P. (2021). Clinically malignant breast lesion in an adolescent girl: a case report. Clinics and Practice, 11(3), 435-440. https://doi.org/10.3390/clinpract11030058
12. Yeh, E., Jacene, H., Bellon, J., Nakhlis, F., Birdwell, R., Georgian-Smith, D., … & Abbeele, A. (2013). What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach. Radiographics, 33(7), 2003-2017. https://doi.org/10.1148/rg.337135503